122Indexed trials
mesh condition
Seizures
Intelligence
Seizures intelligence: 122 indexed trials, 22 recruiting studies, 88 sponsors across 61 countries.
22Recruiting
88Sponsors
61Countries
Leading sponsors
National Institute of Neurological Disorders and Stroke (NINDS)60 recruiting
GlaxoSmithKline60 recruiting
Jazz Pharmaceuticals41 recruiting
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.40 recruiting
Dartmouth-Hitchcock Medical Center31 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.30 recruiting
Eisai Inc.31 recruiting
Johns Hopkins University20 recruiting
NYU Langone Health21 recruiting
Eisai Co., Ltd.20 recruiting
Beth Israel Deaconess Medical Center21 recruiting
Children's Hospital Medical Center, Cincinnati20 recruiting
Geographic activity
United States70trials
United Kingdom16trials
France16trials
Spain15trials
Germany14trials
Italy10trials
Australia10trials
Poland10trials
Hungary8trials
India8trials
Netherlands8trials
Belgium8trials
Leading interventions
Levetiracetam5trials
Perampanel4trials
topiramate3trials
Lamotrigine3trials
SPN-8172trials
Survey2trials
Topiramate2trials
Vagus Nerve Stimulation Therapy2trials
Beethoven's Für Elise1trials
COBENFY KarXT (50/20 mg)1trials
Basimglurant with crossover to Placebo1trials
Anodal tDCS of left or right AG or FC1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.